App-Quantinova.ai

BEHCE-S DISEASE: CLINICAL AND IMMUNOLOGIC MANIFESTATIONS IN A COHORT OF 377 PATIENTS

M. Rodriguez Carballeira - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Thalidomide

CAN THROMBOLOELASTOGRAPHY BE A NEW TOOL TO ASSES THE RISK OF THROMBOSIS IN BEHCE-S DISEASE?

S. Yasar Bilge - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

Fibrinogen (IV)

THE CLINICAL COURSE OF THE ACUTE DEEP VEIN THROMBOSIS OF THE LEGS IN BEHCE-S SYNDROME

Y. Ozguler - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

JUVENILE TEMPORAL ARTERITIS: REPORT OF A CASE AND REVIEW OF THE LITERATURE

C. Campochiaro - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

MEDIASTINAL FIBROSIS COMBINED WITH BEHCE-S DISEASE: FIVE CASE REPORTS

I. Gharsallah - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Colchicine

OCULAR MANIFESTATIONS OF BEHCE-S DISEASE

R.G. Goloeva - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

HAS RITUXIMAB (RTX) A ROLE IN TREATMENT OF CHRONIC NON-RENAL HENOCH-SCHONLEIN PURPURA (HSP)? 9 YEARS FOLLOW UP OF A PATIENT WITH SEVERE GASTRO-INTESTINAL DISEASE

S. Tosounidou - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methylprednisolone

COMPETING RISK OF MAJOR ADVERSE CARDIAC EVENTS AND MAJOR BLEEDING IN THE ERA OF NEW ANTIPLATELET THERAPY: A META-ANALYSIS OF RANDOMIZED TRIALS

Georges El-Hayek - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

PROTEINURIA IS INDEPENDENTLY ASSOCIATED WITH HIGH ON TREATMENT PLATELET REACTIVITY IN PATIENTS ON CLOPIDOGREL BUT NOT ASPIRIN FOR THE TREATMENT OF MAJOR ADVERSE CARDIOVASCULAR EVENTS

Carlos D. Davila - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

ELECTROCARDIOGRAPHIC CHARACTERISTICS OF LEFT MAIN CORONARY ARTERY ST-ELEVATION MYOCARDIAL INFARCTION: RESULTS FROM A MULTICENTER REGISTRY

Kelvin Chua - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

DRUG-ELUTING STENTS VERSUS BARE METAL STENTS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Bilal Iqbal - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

LEFT MAIN CORONARY ARTERY ST-ELEVATION MYOCARDIAL INFARCTION: CLINICAL CHARACTERISTICS AND OUTCOMES FROM A MULTICENTER REGISTRY

Khung Keong Yeo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OPTIMIZING P2Y12-RECEPTOR INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS BASED ON PLATELET FUNCTION TESTING: IMPACT OF PRASUGREL AND HIGH-DOSE CLOPIDOGREL

Daniel Aradi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

BALANCING RISKS OF BLEEDING AND STENT THROMBOSIS: A DECISION ANALYTIC MODEL TO COMPARE DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTS

Benjamin Galper - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

ANTITHROMBOTIC POTENCY OF TICAGRELOR VERSUS CLOPIDOGREL, WHEN ADMINISTERED WITH BIVALIRUDIN

Mohammad Urooj Zafar - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

COMPARISON OF PLATELET REACTIVITY AND CLINICAL OUTCOMES IN PATIENTS TREATED WITH CLOPIDOGREL AND CORONARY INTERVENTION

Min Kim - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

ASSOCIATION BETWEEN ABCB1 POLYMORPHISMS, THROMBELASTOGRAPHY AND RISK OF BLEEDING EVENTS IN CLOPIDOGREL-TREATED CHINESE PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION

Jia-Hui Zhang - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

CLOPIDOGREL ALONE IS NOT SUFFICIENT TO PREVENT STENT THROMBOSIS IN DIABETIC PATIENTS REQUIRING WARFARIN

Pongpeera Taytawat - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

CYP2C19 LOSS-OF-FUNCTION ALLELE GENOTYPING COMBINED WITH THROMBELASTOGRAPH PLATELET-MAPPING ASSAY IS AN INDEPENDENT PREDICTOR OF ADVERSE CARDIOVASCULAR OUTCOMES IN CHINESE PATIENTS TREATED WITH CLOPIDOGREL UNDERGOING CORONARY STENTING

Xiao-Fang Tang - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

COMPARISON OF CIRCULATING DENDRITIC CELLS AND MONOCYTE SUBSETS AT DIFFERENT STAGES OF ATHEROSCLEROSIS

Jianhui Zhuang - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Filters

7277 Abstracts